Immucell (ICCC) Research & Development (2009 - 2026)
Immucell's Research & Development was $176,771 in Q3 2026, down 74.5% from $694,311 a year earlier but up 47.7% from the prior quarter.
Immucell (ICCC) Research & Development (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immucell's Research & Development was $1.37 million through Sep 30, 2026, down 55.7% year-over-year; for FY2025, it was $3.04 million, down 22.0% from FY2024.
- Research & Development has now declined for three consecutive years, with a five-year compound annual growth rate of -6.9% (FY2020 to FY2025).
- In earlier years, Research & Development was $3.9 million in FY2024 (-11.3%), $4.39 million in FY2023 (-2.2%), $4.49 million in FY2022 (+7.8%) and $4.17 million in FY2021 (-4.3%).
- Quarterly Research & Development has moved between $119,652 (Q2 2026) and $1.27 million (Q3 2022) over five years.
- Compared with a year earlier, Research & Development has declined for seven straight quarters, with an average decline of 42.4% over the last seven quarters.
- The best year-over-year quarter for Research & Development over five years was Q3 2022 (growth of 21.2%); the worst was Q2 2026 (a decline of 85.6%).
- Per Business Quant data, ICCC's Research & Development in the three quarters before Q3 2026 was $119,652 (Q2 2026), $317,688 (Q1 2026) and $758,864 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | 176,771.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 176,771.00 |
| Jun 30, 2026 | 119,652.00 |
| Mar 31, 2026 | 317,688.00 |
| Dec 31, 2025 | 758,864.00 |
| Sep 30, 2025 | 694,311.00 |
| Jun 30, 2025 | 831,858.00 |
| Mar 31, 2025 | 756,847.00 |
| Dec 31, 2024 | 819,393.00 |
| Sep 30, 2024 | 786,136.00 |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 1.27 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 1.05 Mn |
Immucell Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();